These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 18721833)

  • 1. BioTimer Assay, a new method for counting Staphylococcus spp. in biofilm without sample manipulation applied to evaluate antibiotic susceptibility of biofilm.
    Pantanella F; Valenti P; Frioni A; Natalizi T; Coltella L; Berlutti F
    J Microbiol Methods; 2008 Dec; 75(3):478-84. PubMed ID: 18721833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of sub-inhibitory antibiotics and flow condition on Staphylococcus aureus ATCC 6538 biofilm development and biofilm growth rate: BioTimer assay as a study model.
    Berlutti F; Frioni A; Natalizi T; Pantanella F; Valenti P
    J Antibiot (Tokyo); 2014 Nov; 67(11):763-9. PubMed ID: 24865865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal attachment killing (MAK): a versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis.
    Knobloch JK; Von Osten H; Horstkotte MA; Rohde H; Mack D
    Med Microbiol Immunol; 2002 Oct; 191(2):107-14. PubMed ID: 12410350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of ultrasound with antibiotics released from bone cement decreases the viability of planktonic and biofilm bacteria: an in vitro study with clinical strains.
    Ensing GT; Neut D; van Horn JR; van der Mei HC; Busscher HJ
    J Antimicrob Chemother; 2006 Dec; 58(6):1287-90. PubMed ID: 17041238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.
    Smith K; Perez A; Ramage G; Gemmell CG; Lang S
    Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.
    García-Castillo M; Morosini MI; Gálvez M; Baquero F; del Campo R; Meseguer MA
    J Antimicrob Chemother; 2008 Nov; 62(5):1027-30. PubMed ID: 18753188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus : comparison with other drugs.
    Cafiso V; Bertuccio T; Spina D; Purrello S; Stefani S
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):466-9. PubMed ID: 20528931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a feasible method for determination of biofilm antimicrobial susceptibility in staphylococci.
    Antunes AL; Trentin DS; Bonfanti JW; Pinto CC; Perez LR; Macedo AJ; Barth AL
    APMIS; 2010 Nov; 118(11):873-7. PubMed ID: 20955460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended antimicrobial susceptibility assay for Staphylococcus aureus isolates from bovine mastitis growing in biofilms.
    Melchior MB; Fink-Gremmels J; Gaastra W
    Vet Microbiol; 2007 Nov; 125(1-2):141-9. PubMed ID: 17600640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative assessment of the antimicrobial susceptibility of Staphylococcus aureus isolates from bovine mastitis in biofilm versus planktonic culture.
    Melchior MB; Fink-Gremmels J; Gaastra W
    J Vet Med B Infect Dis Vet Public Health; 2006 Sep; 53(7):326-32. PubMed ID: 16930277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions.
    Sauer K; Steczko J; Ash SR
    J Antimicrob Chemother; 2009 May; 63(5):937-45. PubMed ID: 19282330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY; Ko KS; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.
    Peeters E; Nelis HJ; Coenye T
    J Antimicrob Chemother; 2009 Oct; 64(4):801-9. PubMed ID: 19633000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
    Gracia E; Laclériga A; Monzón M; Leiva J; Oteiza C; Amorena B
    J Surg Res; 1998 Oct; 79(2):146-53. PubMed ID: 9758730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
    Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
    Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms.
    Toté K; Berghe DV; Deschacht M; de Wit K; Maes L; Cos P
    Int J Antimicrob Agents; 2009 Jun; 33(6):525-31. PubMed ID: 19179053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in biofilm development and antibiotic susceptibility among Streptococcus pneumoniae isolates from cystic fibrosis samples and blood cultures.
    García-Castillo M; Morosini MI; Valverde A; Almaraz F; Baquero F; Cantón R; del Campo R
    J Antimicrob Chemother; 2007 Feb; 59(2):301-4. PubMed ID: 17142818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations.
    Keays T; Ferris W; Vandemheen KL; Chan F; Yeung SW; Mah TF; Ramotar K; Saginur R; Aaron SD
    J Cyst Fibros; 2009 Mar; 8(2):122-7. PubMed ID: 19064337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.